Jiangsu Hengrui Pharmaceuticals News

Hengrui Pharmaceutical's Announcement on Subsidiaries Obtaining Approval Notices for Drug Clinical Trials

Apr 23 00:00

Hengrui Pharmaceutical's Announcement on Subsidiaries Obtaining Approval Notices for Drug Clinical Trials

Apr 19 00:00

Hengrui Pharmaceutical's Announcement on the Company's Drug Obtaining Fast Track Qualification from the US FDA

Apr 19 00:00

Hengrui Pharmaceutical's Announcement on Subsidiaries Obtaining Approval Notices for Drug Clinical Trials

Apr 19 00:00

Hengrui Pharmaceutical's Announcement on Holding Results Briefings for the First Quarter of 2023 and 2024

Apr 19 00:00

Announcement of Resolutions of the 7th Meeting of the 9th Board of Directors of Hengrui Pharmaceutical

Apr 18 00:00

Hengrui Pharmaceutical Board Audit Committee Implementation Rules (2024 Revision)

Apr 18 00:00

Hengrui Pharmaceutical Board Nomination Committee Implementation Rules (2024 Revision)

Apr 18 00:00

Hengrui Pharmaceutical Board Strategy Committee Implementation Rules (2024 Revision)

Apr 18 00:00

Hengrui Pharmaceutical Independent Director Work System

Apr 18 00:00

Hengrui Pharmaceutical Board Remuneration and Assessment Committee Implementation Rules (2024 Revision)

Apr 18 00:00

Hengrui Pharmaceutical\'s 2024 “Improve Quality, Increase Efficiency, and Value Rewards” Action Plan

Apr 18 00:00

Summary of Hengrui Pharmaceutical\'s 2023 Annual Report

Apr 18 00:00

Hengrui Pharmaceutical 2023 Annual Report

Apr 18 00:00

Hengrui Pharmaceutical 2023 Audit Report

Apr 18 00:00

Special note on the 2023 non-operating capital occupation and other related capital transactions of Jiangsu Hengrui Pharmaceutical Co., Ltd.

Apr 18 00:00

Hengrui Pharmaceutical 2023 Independent Director Debriefing Report (Zeng Qingsheng)

Apr 18 00:00

2023 Internal Control Evaluation Report

Apr 18 00:00

Hengrui Pharmaceutical 2023 Environmental, Social and Governance Report

Apr 18 00:00

Hengrui Pharmaceutical 2023 Internal Control Audit Report

Apr 18 00:00